Psilocybin Treatments

Debate between Robert Jenrick and Ronnie Cowan

Thursday 18th May 2023 Commons Chamber

[Robert Jenrick]

I am by no means an expert in this field, but I think I am suggesting that were this to be a drug that is licensed, it would need to go through the MHRA process in the usual way.

I would like to come to a point made by the hon. Lady earlier around the costs involved in a first-time application for a controlled drug licence of the kind we have been discussing. She quoted a substantial figure, which would be concerning as it would be prohibitively costly for smaller manufacturers or researchers. The figures that I have been quoted are that first-time application for a licence costs £3,700 and a standard renewal costs £326. I will write to the hon. Lady with those figures and if she contests them in any way, then I or the Minister for Crime, Policing and Fire, my right hon. Friend the Member for Croydon South (Chris Philp) will be happy to respond.

[Ronnie Cowan]

The cost is not just about the licence. Because it is a schedule 1 drug, more dangerous than heroin, the way in which it is stored in a laboratory, so that people cannot get access to it, and the set-up needed around the laboratory has caused a lot of people to say that they simply cannot afford to make such modifications to their laboratories and start the investigation in the first place.

[Robert Jenrick]

I see that point. In a moment, I will come on to the work that the Government are doing in that regard, and more broadly, to facilitate research and make it more accessible to a broader range of organisations.

To finish the point about the process involved, once granted a medicine licence by the MHRA, medicines can be assessed by the National Institute for Health and Care Excellence, which makes recommendations about routine prescribing on the NHS.

I thank the hon. Members who described the promising research emerging on the potential benefit of psilocybin. Studies in the UK include publicly funded research. For example, the National Institute for Health and Care Excellence is funding King’s College London to carry out a trial evaluating the feasibility, safety and efficacy of psilocybin for adults who are unresponsive to or intolerant of treatment for depression.

In January last year, King’s College London published the results of a small-scale study suggesting that psilocybin can be administered safely, under certain circumstances and to healthy individuals. That is clearly encouraging. However, the researchers acknowledge that larger and longer trials, including comparison with existing treatments, would be required to determine the efficacy and safety of psilocybin for this disorder.

Asylum Seekers Accommodation and Safeguarding

Debate between Robert Jenrick and Ronnie Cowan

Monday 7th November 2022 Commons Chamber

[Robert Jenrick]

My hon. Friend is absolutely right that the burden of migrants in hotel and other accommodation has historically been borne by our cities, and that Stoke has disproportionately borne a significant quantity of migrants. We have now tried to disperse individuals more broadly, and some of the issues that we have heard about today are a result of migrants being placed in hotels in locations where that would not previously have happened, so it is a new issue for those local authorities to cope with. We need to ensure that we provide the right support to those local authorities. We now have a dispersal strategy to encourage individuals to be placed more fairly across the country, which we hope should in time provide a fairer settlement for places such as Stoke-on-Trent.

[Ronnie Cowan (Inverclyde) (SNP)]

If the dispersal strategy is to be successful, local authorities must be engaged in a conversation before they are told what is happening in their own local authority. That way, we can ensure that the correct support, services and funding are in place. Otherwise, does the Minister not just risk fuelling the increasing intolerance and bigotry?

[Robert Jenrick]

The hon. Gentleman is right. My first priority was to ensure that the Manston site was operating legally and appropriately, which meant that the Home Office had to procure accommodation at pace. We are now moving into the next phase, which will involve ensuring that we have better communication and engagement with local authorities, so that we can hear their concerns; that we provide them with the support that they might need; and that we choose locations together that meet sensible criteria in terms of safeguarding, community cohesion and the availability of public services. It is also extremely important that we work closely with local authorities on issues such as child protection and the appropriate dispersal of children and families across the country.